Anlon Healthcare IPO Itemizing: Anlon Healthcare shares are set to checklist within the Indian inventory market at present. The preliminary public providing (IPO) of the chemical manufacturing firm noticed respectable demand, and the Anlon Healthcare IPO itemizing date is at present, 3 September 2025.
The general public problem was open from August 26 to 29. Anlon Healthcare IPO itemizing date is at present and the fairness shares of the corporate can be listed on each the inventory exchanges, BSE and NSE.
“Buying and selling Members of the Trade are hereby knowledgeable that efficient from Wednesday, September 3, 2025, the fairness shares of ANLON HEALTHCARE LIMITED shall be listed and admitted to dealings on the Trade within the checklist of ‘T’ Group of Securities,” a discover on the BSE stated.
Anlon Healthcare shares can be part of Particular Pre-open Session (SPOS) on Wednesday, September 3, 2025, it added, and the inventory can be out there for buying and selling from 10:00 AM. The scrip can be within the Commerce-for-Commerce phase for 10 buying and selling days.
Forward of the Anlon Healthcare share itemizing at present, the tendencies within the gray market premium (GMP) and analysts sign a muted debut of shares. Right here’s what Anlon Healthcare IPO GMP at present signifies.
Anlon Healthcare IPO GMP In the present day
Anlon Healthcare IPO GMP at present has dropped to ₹1 per share, market specialists stated. This means that within the gray market, Anlon Healthcare shares are buying and selling greater by ₹1 apiece than their problem worth.
Anlon Healthcare IPO Itemizing Value
Anlon Healthcare IPO GMP at present alerts that the estimated itemizing worth of Anlon Healthcare shares could be ₹92 apiece, a premium of 1.1% to the difficulty worth of ₹91 per share.
Analysts additionally anticipate Anlon Healthcare IPO itemizing to be muted as seen within the tendencies within the GMP at present.
“Anlon Healthcare IPO has attracted consideration as a distinct segment play within the energetic pharmaceutical substances (API) area. Nonetheless, valuation stays a central query. On the higher worth of ₹91, the difficulty implies a P/E of almost 24x FY25 earnings, stretching to 50x if measured on FY24 earnings. This locations the IPO at a premium relative to many listed friends, regardless of its smaller base. Whereas robust RoNW above 50% and sturdy DMF pipeline present consolation, the aggressive pricing suggests restricted room for short-term itemizing positive aspects,” stated Bhavik Joshi Enterprise Head INVasset PMS.
On stability, he believes the itemizing may see average demand from traders looking for differentiated pharma publicity, however sustained efficiency will hinge on execution of its product pipeline, regulatory clearances, and the power to scale exports with out margin dilution.
Anlon Healthcare IPO Subscription Standing, Key Particulars
The IPO was open for subscription from Tuesday, August 26 to Friday, August 29. The IPO allotment date was September 1, and the Anlon Healthcare IPO itemizing date is September 3. Anlon Healthcare shares can be listed on BSE and NSE.
The corporate raised ₹121.03 crore from the book-building problem which was fully a contemporary problem of 1.33 crore fairness shares, bought on the IPO worth band of ₹86 to ₹91 per share.
Anlon Healthcare IPO was subscribed 7.13 instances in whole, NSE information confirmed. The general public problem was booked 47.30 instances within the Retail Particular person Buyers (RIIs) class, and 10.61 instances within the Non Institutional Buyers (NII) phase. The Certified Institutional Patrons (QIBs) class acquired 1.07 instances subscription.
Interactive Monetary Companies Ltd. is the guide working lead supervisor and Kfin Applied sciences Ltd. is the Anlon Healthcare IPO registrar.
Disclaimer: The views and suggestions made above are these of particular person analysts or broking firms, and never of Mint. We advise traders to verify with licensed specialists earlier than making any funding choices.
